首页 > 市场调查报告书 > 医疗设备

感测器生技设备

市场调查报告书

商品编码

1527813

全球生物感测器市场：市场规模、份额、成长分析 - 按类型、按产品、按技术、按组件、按应用、按最终用户、按地区、行业预测，2024-2031 年

Biosensors Market Size, Share, Growth Analysis, By Type, Product, Technology, Component, Application, End-User, and Region - Industry Forecast 2024-2031

出版日期: 2024年07月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球生物感测器市场规模将达到约267.6亿美元，2023年将达到289亿美元，2024-2031年预测期间复合年增长率为8.0%，2031年将达到535亿美元，预计将达到90美元百万。

由于奈米技术和生物技术的进步，生物感测器市场正在经历快速成长。这些下一代感测器提高了检测细菌细胞和其他生物分子的效率和准确性，并在医疗保健、农业和食品安全等多个领域中得到应用。医疗保健产业依靠生物感测器进行血糖监测、尿道结石检测、药物浓度追踪等。食品和饮料行业也使用生物感测器进行品管和安全。将生物感测器整合到智慧型手錶等可穿戴设备中正在进一步扩大市场潜力。随着技术的进步，生物感测器将在各行业中发挥越来越重要的作用。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 义大利
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Abbott Laboratories（US）
Roche Diagnostics-（Switzerland）
Johnson & Johnson（US）
Medtronic（Ireland）
Siemens Healthcare GmbH（Germany）
GE Healthcare（US）
LifeScan, Inc.（US）
Bio-Rad Laboratories（US）
Nova Biomedical（US）
Dexcom（US）
AgaMatrix, Inc.（US）
Biosensors International Group, Ltd.（Singapore）
Sysmex Corporation（Japan）
F. Hoffmann-La Roche AG（Switzerland）
PTS Diagnostics（US）
Acon Laboratories, Inc.（US）
Medtronic Diabetes（US）
Universal Biosensors, Inc.（Australia）
Analog Devices, Inc.（US）
Lifescan Medical Devices Co., Ltd.（China）
Biosensing Instrument, Inc.（US）
Miraculins Inc.（Canada）
I-SENS, Inc.（South Korea）
LifeSensors, Inc.（US）
GlySens Incorporated（US）

简介目录

Product Code: SQMIG45J2077

Global Biosensors Market size was valued at around USD 26.76 billion in 2022 and is poised to grow from USD 28.9 billion in 2023 to USD 53.59 billion by 2031, at a CAGR of 8.0% over the forecast period (2024-2031).

The biosensor market is experiencing rapid growth driven by advancements in nanotechnology and biotechnology. These next-generation sensors offer enhanced efficiency and accuracy in detecting bacterial cells and other biomolecules, finding applications in diverse sectors like healthcare, agriculture, and food safety. The healthcare industry is a major adopter, utilizing biosensors for glucose monitoring, UTI detection, and drug level tracking. Additionally, the food and beverage industry employs biosensors for quality control and safety. The integration of biosensors into wearable devices, such as smartwatches, is further expanding market potential. As technology continues to evolve, biosensors are poised to play an increasingly critical role in various industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosensors Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosensors Market Segmental Analysis

Global Biosensors Market is segmented by type, product, technology, component, application and region. Based on type, the market is segmented into sensor patch, and embedded device. Based on product the market is segmented into wearable biosensors (wristwear, eyewear, footwear, neckwear, bodywear and others) and non-wearable biosensors. Based on technology, the market is segmented into electrochemical biosensors (amperometric, potentiometric and conductometric), optical biosensors (SPR, colorimetric and fluorescence), piezoelectric biosensors (acoustic and microcantilever), thermal biosensors, and nanomechanical biosensors. Based on component, the market is segmented into bioreceptor molecules, biological elements, and transducer. Based on application, the market is segmented into POC (glucose monitoring, cardiac marker, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas & electrolyte detection, detection of tumor or cancer marker, urinalysis testing and cholesterol testing), home diagnosis (glucose monitoring, pregnancy testing and cholesterol testing), research labs, environmental monitoring, food and beverages and biodefense. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Biosensors Market

Nanotechnology has revolutionized biosensors, creating devices with nanoscale materials that enhance biological signal detection and transduction. These sensors, often integrated with electrical systems, utilize nanomaterials like nanotubes, nanowires, and nanoparticles to detect various biomolecules. Applications span from glucose monitoring to fluorescence-based detection and biomolecular analysis, demonstrating the versatility of nanotechnology in biosensing.

Restraints in the Global Biosensors Market

The biosensor market faces significant challenges hindering widespread adoption. High production costs and limited demand outside healthcare have slowed the commercialization of this promising technology. Expanding biosensor applications into areas like biodefense, military, and environmental monitoring is hampered by insufficient research and development. Additionally, consumer acceptance, price sensitivity, and concerns about product reliability further impede market growth.

Market Trends of the Global Biosensors Market

Wearable biosensors are driving significant growth in the biosensor market. These small, non-invasive devices, often integrated into smartwatches and fitness trackers, monitor various health parameters like heart rate, blood glucose, and sleep patterns. Advancements in sensor technology have made them smaller, more efficient, and suitable for continuous wear. The increasing prevalence of chronic diseases, coupled with the rise of digital health and remote patient monitoring, is fueling demand. As wearable biosensors become more accessible and affordable, they are poised to revolutionize healthcare by providing individuals with valuable insights into their health and enabling proactive management of chronic conditions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Patent Analysis
Value Chain Analysis
Trade Analysis
Ecosystem of the Market
Case Study Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Biosensors Market by Type

Market Overview
Sensor Patch
Embedded Devices

Biosensors Market by Product

Market Overview
Wearable Biosensors
- Wristwear
- Eyewear
- Footwear
- Neckwear
- Bodywear
- Others
Wearable Biosensors

Biosensors Market by Technology

Market Overview
Electrochemical Biosensors
- Amperometric
- Potentiometric
- Conductometric
Optical Biosensors
- SPR
- Colorimetric
- Fluorescence
Piezoelectric Biosensors
- Acoustic
- Microcantilever
Thermal Biosensors
Nanomechanical Biosensors

Biosensors Market by Component

Market Overview
Bioreceptor Molecules
Biological Elements
Transducer

Biosensors Market by Application

Market Overview
POC
- Glucose Monitoring
- Cardiac Marker
- Infectious Disease Detection
- Coagulation Monitoring
- Pregnancy Testing
- Blood Gas & Electrolyte Detection
- Detection of Tumor or Cancer Marker
- Urinalysis Testing
- Cholesterol Testing
Home Diagnosis
- Glucose Monitoring
- Pregnancy Testing
- Cholesterol Testing
Research Labs
Environmental Monitoring
Food and Beverages
Biodefense

Biosensors Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics -(Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PTS Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Diabetes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Universal Biosensors, Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analog Devices, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifescan Medical Devices Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensing Instrument, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miraculins Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
I-SENS, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeSensors, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlySens Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments